Laporan Laba Rugi 6242 - TTM - Li Kang Biomedical Co., Ltd.

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Li Kang Biomedical Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	429	457	482	514	419	387	395	498	622	684	739	712	653	629	597	572	573	566	577	591
Change (%)		6.40	5.47	6.77	-18.53	-7.65	1.99	26.26	24.90	9.93	7.97	-3.58	-8.32	-3.62	-5.18	-4.09	0.17	-1.37	2.04	2.35
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	145	156	164	174	134	122	125	209	265	296	318	258	222	203	188	179	181	179	184	190
Change (%)		7.65	4.95	6.23	-23.11	-8.61	2.44	67.19	26.59	11.53	7.41	-18.80	-14.06	-8.30	-7.61	-4.50	0.71	-0.66	2.44	3.48
% of Revenue	33.78	34.18	34.01	33.83	31.93	31.60	31.74	42.03	42.59	43.21	42.99	36.20	33.94	32.29	31.46	31.33	31.50	31.73	31.85	32.20

Gross Operating Profit	284	301	318	340	285	265	269	289	357	389	421	454	431	426	409	393	393	386	393	400
Change (%)		5.75	5.75	7.05	-16.18	-7.21	1.79	7.23	23.68	8.75	8.39	7.90	-5.07	-1.22	-4.02	-3.90	-0.08	-1.69	1.85	1.82
% of Revenue	66.22	65.82	65.99	66.17	68.07	68.40	68.26	57.97	57.41	56.79	57.01	63.80	66.06	67.71	68.54	68.67	68.50	68.27	68.15	67.80

SG&A	214	220	227	240	215	207	209	204	236	251	268	300	292	293	295	293	297	296	298	299
Change (%)		2.86	3.51	5.44	-10.18	-3.68	0.59	-2.10	15.70	6.29	6.59	11.92	-2.47	0.16	0.89	-0.71	1.18	-0.24	0.60	0.48
% of Revenue	49.76	48.11	47.21	46.62	51.39	53.61	52.87	40.99	37.97	36.71	36.25	42.07	44.76	46.52	49.50	51.24	51.76	52.36	51.61	50.67

R&D	0
Change (%)
% of Revenue	0.00

OpEx	359	376	391	414	349	330	334	414	501	547	585	558	514	496	483	473	477	475	482	489
Change (%)		4.79	4.11	5.77	-15.62	-5.57	1.28	23.89	21.21	9.06	7.03	-4.75	-7.83	-3.49	-2.59	-2.18	1.01	-0.40	1.29	1.62
% of Revenue	83.54	82.28	81.21	80.45	83.32	85.21	84.61	83.02	80.57	79.93	79.23	78.27	78.70	78.81	80.96	82.57	83.26	84.08	83.46	82.88

Operating Income	71	81	90	101	70	57	61	85	121	137	153	155	139	133	114	100	96	90	95	101
Change (%)		14.52	11.83	11.10	-30.49	-18.08	6.13	39.29	42.94	13.56	11.69	0.88	-10.11	-4.13	-14.80	-12.20	-3.80	-6.20	6.00	5.99
% of Revenue	16.46	17.72	18.79	19.55	16.68	14.79	15.39	16.98	19.43	20.07	20.77	21.73	21.30	21.19	19.04	17.43	16.74	15.92	16.54	17.12

Interest Expense	-1	-1	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-1	-1	-1	-1	-1	-0	-0
Change (%)		-10.49	-10.26	-4.69	-4.93	2.48	-5.05	-0.93	-3.27	-29.95	-31.38	-52.76	169.15	144.27	50.81	28.22	-15.82	-31.11	-41.13	-60.05
% of Revenue	-0.14	-0.12	-0.10	-0.09	-0.11	-0.12	-0.11	-0.09	-0.07	-0.04	-0.03	-0.01	-0.04	-0.10	-0.16	-0.21	-0.18	-0.12	-0.07	-0.03

Net Income	60	69	75	79	61	51	55	73	98	112	126	129	116	111	95	84	82	77	81	86
Change (%)		14.59	8.21	5.69	-22.74	-15.96	7.61	32.56	33.09	14.79	12.67	1.88	-9.78	-4.39	-14.09	-11.96	-2.33	-6.06	5.67	5.36
% of Revenue	14.08	15.17	15.56	15.40	14.61	13.29	14.02	14.72	15.69	16.38	17.10	18.06	17.78	17.64	15.98	14.67	14.30	13.62	14.10	14.52

Source: Capital IQ

Li Kang Biomedical Co., Ltd. - Laporan Laba Rugi (TTM)

Laporan Laba Rugi (TTM)